Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société …

R Guilhaumou, S Benaboud, Y Bennis… - Critical Care, 2019 - Springer
Background Beta-lactam antibiotics (βLA) are the most commonly used antibiotics in the
intensive care unit (ICU). ICU patients present many pathophysiological features that cause …

Management of sepsis and septic shock in the emergency department

F Gavelli, LM Castello, GC Avanzi - Internal and emergency medicine, 2021 - Springer
Early management of sepsis and septic shock is crucial for patients' prognosis. As the
Emergency Department (ED) is the place where the first medical contact for septic patients is …

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study

M Tumbarello, F Raffaelli, M Giannella… - Clinical Infectious …, 2021 - academic.oup.com
Background A growing body of observational evidence supports the value of ceftazidime-
avibactam (CAZ-AVI) in managing infections caused by carbapenem-resistant …

Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials

JA Roberts, MH Abdul-Aziz, JS Davis… - American journal of …, 2016 - atsjournals.org
Rationale: Optimization of β-lactam antibiotic dosing for critically ill patients is an intervention
that may improve outcomes in severe sepsis. Objectives: In this individual patient data meta …

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam …

MH Abdul-Aziz, H Sulaiman, MB Mat-Nor, V Rai… - Intensive care …, 2016 - Springer
Purpose This study aims to determine if continuous infusion (CI) is associated with better
clinical and pharmacokinetic/pharmacodynamic (PK/PD) outcomes compared to intermittent …

Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

Brazil nuts: Nutritional composition, health benefits and safety aspects

BR Cardoso, GBS Duarte, BZ Reis… - Food Research …, 2017 - Elsevier
Brazil nuts are among the richest selenium food sources, and studies have considered this
Amazonian nut as an alternative for selenium supplementation. Besides selenium, Brazil …

[HTML][HTML] An approach to antibiotic treatment in patients with sepsis

ML Martínez, EP Plata-Menchaca… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Sepsis is a medical emergency and life-threatening condition due to a dysregulated host
response to infection, which is time-dependent and associated with unacceptably high …

Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …

DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - Springer
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis

Z Yu, X Pang, X Wu, C Shan, S Jiang - PloS one, 2018 - journals.plos.org
Background Meropenem exhibits time-dependent antimicrobial activity and prolonged
infusion (PI)(extended infusion or continuous infusion, EI or CI) of meropenem can better …